Adult Arm of DZL All Age Asthma Cohort (ALLIANCE)

NCT02419274 · tracked via the Priya Life Science Germany tracker

Sponsor

LungenClinic Grosshansdorf

Phase

Observational

Started

2014-03

Last updated

2023-10-12

Condition(s) studied

Asthma

Study summary

Deep Phenotyping of adult asthma patients:

* severity from mild to severe
* both atopic and non-atopic
* both childhood and adult onset
* both smokers and non-smokers
* corresponding pediatric cohort (Pediatric Arm of DZL All Age Asthma Cohort) with equivalent SOPs regarding collection of biomaterial and clinical data incl. lung function, further processing of biomaterial and further analyses

Eligibility

Sex

ALL

Min age

18 Years

Max age

99 Years

Healthy volunteers

Accepted

Inclusion Criteria: * Proven Diagnosis according to current GINA Guideline (2014) * Ability to read and understand German * Ability to understand and agree to informed consent Exclusion Criteria: * History of respiratory tract infection within the last 4 weeks before inclusion

Primary outcome measure(s)

Defining clinical asthma phenotypes by combining clinical, lung function and biomaterial data — 2 years

Trial sites (1)

Facility	City	Region	Status
LungenClinic Grosshansdorf	Großhansdorf	Germany	Recruiting

More LungenClinic Grosshansdorf trials in Germany

HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections Starting soon

Other trials for the same condition

Depemokimab Asthma Imaging and Bronchoscopy Sub-Study Recruiting

Investigation of the Effects of Oxidized Antigens on the T-Cell Response and the Epigenetic Reprogramming of Neutrophils in Lung Diseases - OXIGENE - Starting soon

A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD Active, not recruiting

Pediatric Arm of DZL All Age Asthma Cohort Recruiting

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02419274 on ClinicalTrials.gov ↗ ← All trials in Germany